Antaros Medical is a pioneering company dedicated to transforming drug development through innovative imaging techniques. Specializing in cardiorenal and metabolic diseases, Antaros Medical combines extensive experience in drug development with a deep understanding of disease mechanisms. The company collaborates with a global network of partners, including major pharmaceutical companies and biotechs, as well as participating in European initiatives like the Innovative Medicines Initiative (IMI). With a focus on delivering both small, complex mechanistic studies and large, streamlined multi-center clinical trials, Antaros Medical operates its global headquarters and analysis Corelab in Sweden. The company values its people and fosters a collaborative culture, emphasizing teamwork and high-quality outcomes in a fast-paced environment.